Digital Therapeutics (DTx) Market Growth, Size, Share, Industry Report and Forecast 2021-2027
The global digital therapeutics (DTx) market is anticipated to grow at a considerable CAGR of 29.0% during the forecast period (2021-2027). The growing pervasiveness of chronic diseases is one of the prime factors affecting and driving the market. According to the World health organization (WHO) around 17.9 million people across the globe die due to cardiovascular diseases (CVD) every year. Chronic diseases are having high levels of uncertainty and a new care lifestyle would support their behaviour. Through digital health technology, it will enhance prevention, diagnosis along with proper management of cardiovascular diseases that leads to getting better health outcomes.
To Request a Sample of our Report on Digital
Therapeutics (DTx) Market: https://www.omrglobal.com/request-sample/digital-therapeutics-market
The key players operating in the global digital therapeutics (DTx) market
had been adopting strategies such as new launches to gain major market share.
For instance, in July 2021, one of the software-enabled healthcare platform
companies across the globe named Happify Health had introduced Ensemble, which
is considered as first transdiagnostic prescription digital therapeutic in
order to do the treatment of patients suffering from Depressive Disorder (MDD)
or Generalized Anxiety Disorder (GAD).
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
·
By Product Type
·
By Sales Channel
·
By Application
• Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
·
Competitive Landscape- Otsuka Pharmaceutical Co., Ltd., Livongo Health,
Omada Health, Inc., WellDoc, and Pear Therapeutics, Inc.
(Get 15% Discount on Buying this Report)
A
full Report of Digital Therapeutics (DTx) Market is Available at: https://www.omrglobal.com/industry-reports/digital-therapeutics-market
Global Digital Therapeutics (DTx) Market
By Product Type
• Software
• Device
By Sales Channel
• B2C
• B2B
By Application
• Preventive Applications
• Treatment/Care-related Applications
Global Digital Therapeutics (DTx) Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Company Profiles
·
Alex Therapeutics AB
·
2Morrow Inc.
·
Akili Interactive Labs. Inc.
·
Ayogo Health
·
Canary Health
·
Click Therapeutics, Inc.
·
CogniFit
·
Ginger
·
HAPPIFY HEALTH
·
Kaia Health
·
Livongo Health
·
Noom, Inc.
·
Mindstrong HealthGmbH
·
Omada Health, Inc.
·
Otsuka Pharmaceutical Co., Ltd.
·
Pear Therapeutics, Inc.
·
ResMed
·
TrialCard
·
Wellthy Therapeutics Pvt Ltd.
·
WellDoc
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment